Web Analytics
AbbVie Earnings Beat Forecasts as Skyrizi Sales Soar 24%. Why the Stock Is Falling. | Deepscope News
MARKET

Select Market Data Region

 August 1, 2026 12:22 AM  finance.yahoo.com Negative

AbbVie Earnings Beat Forecasts as Skyrizi Sales Soar 24%. Why the Stock Is Falling.

Image

AbbVie slashes its full-year guidance to account for its pending acquisition of Apogee Therapeutics.

Continue Reading

Read original source